New York State Common Retirement Fund’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,111
Closed -$35.2K 3192
2024
Q2
$35.2K Buy
10,111
+2,741
+37% +$11.8K ﹤0.01% 3160
2024
Q1
$47K Buy
+7,370
New +$46K ﹤0.01% 2999
2021
Q4
Sell
-27,073
Closed -$177K 3345
2021
Q3
$177K Hold
27,073
﹤0.01% 2952
2021
Q2
$180K Sell
27,073
-7,250
-21% -$45K ﹤0.01% 3083
2021
Q1
$197K Hold
34,323
﹤0.01% 2836
2020
Q4
$307K Sell
34,323
-700
-2% -$7.46K ﹤0.01% 2579
2020
Q3
$408K Buy
35,023
+7,100
+25% +$103K ﹤0.01% 2309
2020
Q2
$448K Buy
27,923
+3,700
+15% +$41K ﹤0.01% 2273
2020
Q1
$145K Buy
24,223
+311
+1% +$2.88K ﹤0.01% 2612
2019
Q4
$316K Hold
23,912
﹤0.01% 2520
2019
Q3
$297K Buy
23,912
+3,850
+19% +$50.9K ﹤0.01% 2572
2019
Q2
$323K Buy
20,062
+13,700
+215% +$306K ﹤0.01% 2587
2019
Q1
$200K Sell
6,362
-450
-7% -$12.8K ﹤0.01% 2722
2018
Q4
$224K Sell
6,812
-300
-4% -$9.87K ﹤0.01% 2660
2018
Q3
$214K Hold
7,112
﹤0.01% 2800
2018
Q2
$191K Buy
+7,112
New +$188K ﹤0.01% 2893

Other funds holding AUTL

New York State Common Retirement Fund's AUTL Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Autolus Therapeutics (AUTL) in Q3 2024, closing a stake of 10,111 shares — an estimated $35.2K sold.

New York State Common Retirement Fund first reported a position in AUTL in Q2 2018 and held it in 16 quarters. The position peaked at $448K in Q2 2020. 101 funds tracked by Wall St. Rank hold AUTL as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Autolus Therapeutics position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 10,111 Autolus Therapeutics shares in Q3 2024, an estimated $35.2K.
  • New York State Common Retirement Fund first reported a position in Autolus Therapeutics in Q2 2018 and held it in 16 quarters.
  • New York State Common Retirement Fund's Autolus Therapeutics position peaked at $448K in Q2 2020.
  • 101 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.